Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.33 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.33 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2160987 | 0.90 | MEN1 (0.47) | MAPK1MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL2170715 | 0.85 | MAPK1 (0.44) | MAPK1MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL12336846 | 0.81 | MEN1 (0.47) | MAPK1MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL2172544 | 0.81 | MEN1 (0.51) | MAPK1MEN1KMT2ATDP1LMNA | |
| SCHEMBL1923135 | 0.81 | MEN1 (0.56) | MAPK1MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL3233026 | 0.80 | MAPK1 (0.51) | MAPK1MEN1KMT2ATDP1CYP3A4 | |
| SCHEMBL2161013 | 0.79 | MAPK1 (0.52) | MAPK1MEN1KMT2ATDP1CYP3A4 | |
| SCHEMBL2172173 | 0.79 | KDM4E (0.52) | MAPK1MEN1KMT2ATDP1CYP3A4 | |
| SCHEMBL2172805 | 0.78 | TTR (0.31) | — | |
| SCHEMBL3237155 | 0.78 | MAPK1 (0.39) | MAPK1MEN1KMT2ATDP1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110190122-A1 | Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them | BASF SE (DE) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190122-A1 | Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them | ABAT, OAT, TYR | MAPK1 1624/4885MEN1 1673/4885KMT2A 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.